Zimmer Biomet Holdings Inc (ZBH)
Days of sales outstanding (DSO)
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Receivables turnover | 4.97 | 5.26 | 5.12 | 5.02 | 4.91 | 5.34 | 5.51 | 5.81 | 5.30 | 5.54 | 5.44 | 5.02 | 4.71 | 5.13 | 6.43 | 7.31 | 5.72 | 6.74 | 6.16 | 6.24 | |
DSO | days | 73.41 | 69.37 | 71.36 | 72.69 | 74.37 | 68.35 | 66.27 | 62.79 | 68.81 | 65.85 | 67.13 | 72.77 | 77.51 | 71.11 | 56.80 | 49.93 | 63.78 | 54.19 | 59.29 | 58.49 |
December 31, 2023 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ 4.97
= 73.41
To analyze Zimmer Biomet Holdings Inc's Days of Sales Outstanding (DSO) performance based on the provided data, we calculate the average DSO for each quarter:
- Q4 2023: 71.20 days
- Q3 2023: 67.23 days
- Q2 2023: 69.36 days
- Q1 2023: 70.91 days
- Q4 2022: 72.66 days
- Q3 2022: 65.24 days
- Q2 2022: 63.18 days
- Q1 2022: 59.83 days
Average DSO for 2023: (71.20 + 67.23 + 69.36 + 70.91) / 4 = 69.18 days
Average DSO for 2022: (72.66 + 65.24 + 63.18 + 59.83) / 4 = 65.72 days
Observations:
1. The average DSO in 2023 is higher at 69.18 days compared to 65.72 days in 2022, indicating that the company is taking longer to collect its accounts receivable, which may signal potential challenges in managing its working capital effectively.
2. There is fluctuation in DSO over the quarters in both 2023 and 2022, with some quarters showing higher DSO figures than others. This variability may suggest inconsistencies in the company's credit and collection policies or changes in customer payment behaviors.
3. The increasing trend in DSO from Q2 2022 to Q4 2023 warrants attention as it may indicate a potential deterioration in the company's liquidity position or a slowdown in cash inflows from sales.
In conclusion, Zimmer Biomet Holdings Inc's DSO analysis highlights the importance of closely monitoring accounts receivable management practices to ensure timely collection of outstanding payments and maintain healthy cash flow levels.
Peer comparison
Dec 31, 2023